Moore Capital Management, LP Ptc Therapeutics, Inc. Transaction History

Moore Capital Management, LP

$5.25 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $141,400 - $206,850	-3,500 Reduced 12.28%	25,000 $1.02 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $57,239 - $73,290	-1,500 Reduced 5.0%	28,500 $1.38 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $335,300 - $547,900	10,000 Added 50.0%	30,000 $1.15 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $837,000 - $1.08 Million	-20,000 Reduced 50.0%	20,000 $1 Million
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $73,569 - $108,342	-1,572 Reduced 3.78%	40,000 $1.89 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $404,206 - $570,069	-8,428 Reduced 16.86%	41,572 $2.54 Million
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $454,099 - $570,700	10,000 Added 25.0%	50,000 $2.34 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $5.52 Million - $10.1 Million	-170,611 Reduced 81.01%	40,000 $1.78 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $897,133 - $1.39 Million	-27,844 Reduced 11.68%	210,611 $10.1 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $1.63 Million - $2.33 Million	48,337 Added 25.42%	238,455 $8.07 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $3.19 Million - $4.06 Million	90,118 Added 90.12%	190,118 $8.56 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $280,900 - $394,900	10,000 Added 11.11%	100,000 $3.76 Million
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $298,300 - $465,100	-10,000 Reduced 10.0%	90,000 $3.09 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $1.93 Million - $3.59 Million	-75,000 Reduced 42.86%	100,000 $3.37 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $2.18 Million - $4.07 Million	125,000 Added 250.0%	175,000 $4.74 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $840,499 - $1.08 Million	50,000	50,000 $1 Million

Others Institutions Holding PTCT

# of Institutions

215

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$338 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.21M
Shares

$309 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$293 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$278 Million
3.78% of portfolio
Armistice Capital, LLC New York, NY

6.96M
Shares

$262 Million
2.77% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Account